Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
The NIH Office of Data Science Strategy is pleased to announce the funding opportunity "The Advancing Health Research through Ethical, Multimodal AI Initiative". Information webinar date: April 19, 2024, 2 pm - 3 pm ET; Letter of Intent Due Date: April 29, 2024. Application Due Date: May 16, 2024.
The Vanderbilt Mouse Metabolic Phenotyping Center (VMMPC) established the Vanderbilt Vibrant Program to support a more inclusive biomedical research community. Through additional funding from the NIH/NIDDK, Vanderbilt Vibrant will provide a travel award (up to $2,000) for select individuals to attend the Metabolic Physiology Meeting 2024.
The ATLAS-D2K Center announces the ATLAS-D2K Opportunity Pool for 2024, fostering innovation in kidney and genitourinary research. Applications due by March 15, 2024.
NIDDK has announced a funding opportunity notice to inform potential applicants that NIDDK will participate, effective immediately in PAR-23-237, Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed).
NIH announced new funding opportunity "Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)" to support the development of in vitro and in vivo models of type 1 diabetes. Letter of Intent Due Date: November 6, 2023. Application Due Date: March 20, 2024.
NIH ODSS announced a new RFI: Best Practice for Sharing NIH Supported Research Software, soliciting input on best practices for openly sharing research software including source code, algorithms, scripts, computational workflows, and executables that were created during the research process or for a research purpose. This RFI will inform and frame the National Institutes of Health’s (NIH) guidance regarding development, refactoring, implementation, and sharing of NIH-supported research software. Response deadline: February 1, 2024.
NIH announced new funding opportunity: The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional). Letter of Intent due Date: September 11, 2023. Application Due Date: October 11, 2023.
NIH announced new funding opportunity: The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional). Letter of Intent due Date: September 11, 2023. Application Due Date: October 11, 2023.
The goal of this program is to advance research methods, identify best practices for scalability, and build capacity for effectively implementing and rigorously evaluating the use of AI/ML algorithms for diagnostic decision-making in real-world settings. Letter of Intent Due: June 30, 2023. Application Due: October 13, 2023.
New funding opportunity was announced by NIDDK: Integration of Novel Measures for Improved Classification of Type 2 Diabetes – Biostatistics Research Center. Letter of Intent Due Date: September 26, 2023. Application Due Date: October 26, 2023.